Returns
NAV and returns as at 20 Aug 2026
Lumpsum · point to point
1W
-0.56%
1M
+0.48%
3M
+4.2%
6M
+13.35%
YTD
+12.78%
1Y
+10.93%
2Y CAGR
+7.68%
3Y CAGR
+18.89%
5Y CAGR
+14.5%
10Y CAGR
+16.06%
SIP · XIRR on monthly instalments
6M SIP
+33.41%
1Y SIP
+20.04%
2Y SIP
+12.23%
3Y SIP
+14.71%
5Y SIP
+18.07%
10Y SIP
+19%
Full history SIP
+19%
Periods up to one year are absolute; longer periods are annualised (CAGR). SIP figures are the XIRR of a fixed monthly instalment over the same window. — means this scheme’s NAV history does not cover that period — across all 1648 schemes, 68% have a 3-year figure, 48.8% a 5-year one, and 32.7% a 10-year one.
Top holdings
as at 31 Jul 2026 · source: AMC monthly portfolio disclosure
Sun Pharmaceutical Industries LimitedPharmaceuticals & Biotechnology
13.31%
Lupin LimitedPharmaceuticals & Biotechnology
7.25%
Divi's Laboratories LimitedPharmaceuticals & Biotechnology
6.52%
Cipla LimitedPharmaceuticals & Biotechnology
6.03%
Apollo Hospitals Enterprise LimitedHealthcare Services
5.3%
Dr. Reddy's Laboratories LimitedPharmaceuticals & Biotechnology
5.01%
Mankind Pharma LimitedPharmaceuticals & Biotechnology
3.74%
Sai Life Sciences LimitedPharmaceuticals & Biotechnology
3.62%
Ajanta Pharma LimitedPharmaceuticals & Biotechnology
3.41%
Max Healthcare Institute LimitedHealthcare Services
3.15%
Top 10 57.34%Securities 35Securities total 97.32%Cash & equivalents 2.68%
The ten largest securities by weight, out of 35 disclosed. Weight is percent of net assets as filed. Cash-equivalent lines (TREPS, reverse repo, net receivables, margin) and derivative legs are counted in the chips above but not ranked among securities, because a short futures leg is filed as a negative weight and sorting it alongside a shareholding describes no portfolio. A portfolio is a point-in-time filing and changes every month.
Risk
Volatility · annualised · 3Y
14.33%
Volatility is the annualised standard deviation of daily NAV moves over the last three years; max drawdown is the deepest peak-to-trough fall in that same window. Where a scheme has less than three years of NAV, the window is what it actually has and is labelled as such — never as three years. Sharpe is as disclosed in the scheme key-ratio feed (as at 24 July 2026).
Beta and alpha are not shown. No benchmark series in the source.
Cost
Expense ratio1%
Category average1.73%
Exit load1%
52W high / low₹647.4211 / ₹539.2707
Expense ratio 1% vs a category average of 1.73% — 0.73 percentage points lower. Among Sectoral/ Thematic schemes disclosing an expense ratio it is 55th of 166, cheapest first.
Expense ratio and category average are as disclosed against this scheme in the source; 78.5% of schemes here carry one. The ratio is charged inside the NAV, so every return on this page is already net of it.
Scheme facts
SEBI sub-category
Sectoral/ Thematic
Plan / option
Direct Growth
Benchmark
BSE Health Care - TRI
Fund manager
Sailesh Raj Bhan
Launched
10 May 2004
NAV history here
10.0y
ISIN
INF204K01I50
AMFI scheme code
118759
SEBI riskometer
Very High
Exit load
1%
Lock-in
None
Minimum lumpsum
₹5,000
Exit load, as disclosed: 1% on or before 1M · Nil after 1M
Not shown on this page, and why
Star rating — GFS is an AMFI-registered distributor (ARN-169480), not a SEBI-registered investment adviser. It does not rate schemes.
Scheme AUM — Scheme-level AUM is not in the source; only AMC-total AUM, which is a different number.
Minimum SIP — Not present in the source.
Beta and alpha — No benchmark series in the source.